rs7338244
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_006475.3(POSTN):c.219-752C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.231 in 151,930 control chromosomes in the GnomAD database, including 4,679 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.23   (  4679   hom.,  cov: 32) 
Consequence
 POSTN
NM_006475.3 intron
NM_006475.3 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  0.192  
Publications
5 publications found 
Genes affected
 POSTN  (HGNC:16953):  (periostin) This gene encodes a secreted extracellular matrix protein that functions in tissue development and regeneration, including wound healing, and ventricular remodeling following myocardial infarction. The encoded protein binds to integrins to support adhesion and migration of epithelial cells. This protein plays a role in cancer stem cell maintenance and metastasis. Mice lacking this gene exhibit cardiac valve disease, and skeletal and dental defects. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Sep 2015] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86). 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.667  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| POSTN | NM_006475.3 | c.219-752C>G | intron_variant | Intron 2 of 22 | ENST00000379747.9 | NP_006466.2 | 
Ensembl
Frequencies
GnomAD3 genomes  0.231  AC: 35025AN: 151812Hom.:  4676  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
35025
AN: 
151812
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.231  AC: 35051AN: 151930Hom.:  4679  Cov.: 32 AF XY:  0.239  AC XY: 17761AN XY: 74242 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
35051
AN: 
151930
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
17761
AN XY: 
74242
show subpopulations 
African (AFR) 
 AF: 
AC: 
9124
AN: 
41468
American (AMR) 
 AF: 
AC: 
4065
AN: 
15246
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
484
AN: 
3468
East Asian (EAS) 
 AF: 
AC: 
3551
AN: 
5178
South Asian (SAS) 
 AF: 
AC: 
1448
AN: 
4816
European-Finnish (FIN) 
 AF: 
AC: 
2568
AN: 
10502
Middle Eastern (MID) 
 AF: 
AC: 
51
AN: 
292
European-Non Finnish (NFE) 
 AF: 
AC: 
13185
AN: 
67946
Other (OTH) 
 AF: 
AC: 
454
AN: 
2104
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.502 
Heterozygous variant carriers
 0 
 1302 
 2603 
 3905 
 5206 
 6508 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 370 
 740 
 1110 
 1480 
 1850 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1521
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.